These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26272182)
1. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p. He T; Qi F; Jia L; Wang S; Wang C; Song N; Fu Y; Li L; Luo Y Cancer Lett; 2015 Nov; 368(1):115-125. PubMed ID: 26272182 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2. He T; Qi F; Jia L; Wang S; Song N; Guo L; Fu Y; Luo Y J Pathol; 2014 Apr; 232(5):499-508. PubMed ID: 24403060 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Angiogenesis by Ultrasound-Mediated MicroRNA-126-3p Delivery. Cao WJ; Rosenblat JD; Roth NC; Kuliszewski MA; Matkar PN; Rudenko D; Liao C; Lee PJ; Leong-Poi H Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2401-11. PubMed ID: 26381870 [TBL] [Abstract][Full Text] [Related]
4. MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2. Zhang H; Ye Q; Du Z; Huang M; Zhang M; Tan H Biomed Pharmacother; 2018 Nov; 107():359-367. PubMed ID: 30099339 [TBL] [Abstract][Full Text] [Related]
5. Angiogenic Mechanisms of Human CD34 Mathiyalagan P; Liang Y; Kim D; Misener S; Thorne T; Kamide CE; Klyachko E; Losordo DW; Hajjar RJ; Sahoo S Circ Res; 2017 Apr; 120(9):1466-1476. PubMed ID: 28298297 [TBL] [Abstract][Full Text] [Related]
6. miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin. Weng C; Dong H; Chen G; Zhai Y; Bai R; Hu H; Lu L; Xu Z Cancer Lett; 2012 Oct; 323(2):171-9. PubMed ID: 22531314 [TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p. Chen S; Chen X; Luo Q; Liu X; Wang X; Cui Z; He A; He S; Jiang Z; Wu N; Chen P; Yu K; Zhuang J Cell Death Dis; 2021 Jul; 12(7):695. PubMed ID: 34257272 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005 [TBL] [Abstract][Full Text] [Related]
9. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer. Kang H; Kim C; Lee H; Rho JG; Seo JW; Nam JW; Song WK; Nam SW; Kim W; Lee EK Cell Death Differ; 2016 Mar; 23(3):484-95. PubMed ID: 26337669 [TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901 [TBL] [Abstract][Full Text] [Related]
12. Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines. Raghu H; Lakka SS; Gondi CS; Mohanam S; Dinh DH; Gujrati M; Rao JS PLoS One; 2010 Aug; 5(8):e12458. PubMed ID: 20805979 [TBL] [Abstract][Full Text] [Related]
13. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling. Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875 [TBL] [Abstract][Full Text] [Related]
14. Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor. Drebert Z; MacAskill M; Doughty-Shenton D; De Bosscher K; Bracke M; Hadoke PWF; Beck IM Vascul Pharmacol; 2017 Feb; 89():19-30. PubMed ID: 27717848 [TBL] [Abstract][Full Text] [Related]
15. MiR-17-3p inhibits angiogenesis by downregulating flk-1 in the cell growth signal pathway. Yin R; Wang R; Guo L; Zhang W; Lu Y J Vasc Res; 2013; 50(2):157-66. PubMed ID: 23258273 [TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through down-regulation of endothelial RAB11FIP2 expression. Sukma Dewi I; Celik S; Karlsson A; Hollander Z; Lam K; McManus JW; Tebbutt S; Ng R; Keown P; McMaster R; McManus B; Öhman J; Gidlöf O Cardiovasc Res; 2017 Apr; 113(5):440-452. PubMed ID: 28073833 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma. Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002 [TBL] [Abstract][Full Text] [Related]
18. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113 [TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978 [TBL] [Abstract][Full Text] [Related]
20. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling. Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]